Ethics of Clinical Science in a Public Health Emergency: Drug Discovery at the Bedside

American Journal of Bioethics 13 (9):3-14 (2013)
  Copy   BIBTEX

Abstract

Clinical research under the usual regulatory constraints may be difficult or even impossible in a public health emergency. Regulators must seek to strike a good balance in granting as wide therapeutic access to new drugs as possible at the same time as gathering sound evidence of safety and effectiveness. To inform current policy, I reexamine the philosophical rationale for restricting new medicines to clinical trials, at any stage and for any population of patients (which resides in the precautionary principle), to show that its objective to protect public health, now or in the future, could soon be defeated in a pandemic. Providing wider therapeutic access and coordinating observations and natural experiments, including service delivery by cluster (wedged cluster trials), may provide such a balance. However, there are important questions of fairness to resolve before any such research can proceed.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 94,593

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

AIDS as a Global Health Emergency.Udo Schüklenk - 1998 - In Helga Kuhse & Peter Singer (eds.), A Companion to Bioethics. Malden, Mass., USA: Wiley-Blackwell. pp. 441–454.

Analytics

Added to PP
2013-10-26

Downloads
24 (#660,087)

6 months
11 (#350,914)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Sarah Edwards
State University of New York, Buffalo